Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:DXCM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDXCMDexCom$71.72-0.5%$63.72$54.11▼$89.98$27.67B1.45.27 million shs866,620 shsBeginner's Guide To Retirement StocksClick the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDXCMDexCom0.00%+10.77%+17.10%-1.35%-14.68%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDXCMDexCom$71.72-0.5%$63.72$54.11▼$89.98$27.67B1.45.27 million shs866,620 shsBeginner's Guide To Retirement StocksClick the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDXCMDexCom0.00%+10.77%+17.10%-1.35%-14.68%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDXCMDexCom 2.92Moderate Buy$82.2114.62% UpsideCurrent Analyst Ratings BreakdownLatest DXCM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/18/2026DXCMDexCom Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetBuy$100.00 ➝ $82.005/18/2026DXCMDexCom BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingUnderweight$67.00 ➝ $64.005/18/2026DXCMDexCom Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$100.00 ➝ $80.005/15/2026DXCMDexCom William BlairSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy5/11/2026DXCMDexCom BenchmarkSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$77.005/11/2026DXCMDexCom BenchmarkSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy5/4/2026DXCMDexCom CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$84.00 ➝ $79.005/1/2026DXCMDexCom Sanford C. BernsteinSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$77.005/1/2026DXCMDexCom Robert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$80.005/1/2026DXCMDexCom MizuhoSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$75.00(Data available from 5/26/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDXCMDexCom$4.66B5.94$2.75 per share26.04$7.66 per share9.36Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDXCMDexCom$836.30M$2.3430.6523.751.1919.31%33.33%13.19%7/29/2026 (Estimated)Latest DXCM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/30/2026Q1 2026DXCMDexCom$0.47$0.56+$0.09$0.51$1.17 billion$1.19 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthDXCMDexComN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDXCMDexCom0.421.951.64Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDXCMDexCom97.75%Insider OwnershipCompanyInsider OwnershipDXCMDexCom0.28%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDXCMDexCom11,000385.87 million384.79 millionOptionableDXCM HeadlinesRecent News About These CompaniesDexcom Uncovers Theft of Scrapped Product, Notifies Potentially Impacted Users28 minutes ago | businesswire.comWilliam Blair Investment Management LLC Purchases Shares of 171,573 DexCom, Inc. $DXCM3 hours ago | marketbeat.comNorthwestern Mutual Wealth Management Co. Acquires 32,392 Shares of DexCom, Inc. $DXCMMay 26 at 4:35 AM | marketbeat.comDexCom, Inc. $DXCM Shares Sold by Ellerson Group Inc. ADVMay 26 at 4:01 AM | marketbeat.comNew Age Alpha Advisors LLC Sells 28,543 Shares of DexCom, Inc. $DXCMMay 25 at 6:17 AM | marketbeat.comIntermede Investment Partners Ltd Takes $60.35 Million Position in DexCom, Inc. $DXCMMay 25 at 6:00 AM | marketbeat.comReviewing Anteris Technologies Global (NASDAQ:AVR) & DexCom (NASDAQ:DXCM)May 24 at 4:57 AM | americanbankingnews.comFideuram Intesa Sanpaolo Private Banking S.P.A. Makes New Investment in DexCom, Inc. $DXCMMay 24 at 4:08 AM | marketbeat.comDexCom, Inc. (NASDAQ:DXCM) Given Average Rating of "Moderate Buy" by BrokeragesMay 23 at 2:29 AM | americanbankingnews.comDexCom, Inc. (NASDAQ:DXCM) Receives Consensus Rating of "Moderate Buy" from AnalystsMay 23 at 2:27 AM | marketbeat.comDexcom: A Medical Platform Play Gaining From AI, Not Disrupted By ItMay 22, 2026 | seekingalpha.comHarnessing medtech market alliances, ŌURA sets IPO plans in motionMay 22, 2026 | medicaldevice-network.comMAnalysts Upgrade DexCom (DXCM) to “Outperform,” Driving Share RecoveryMay 22, 2026 | insidermonkey.comAnalysts Upgrade DexCom (DXCM) to “Outperform,” Driving Share RecoveryMay 22, 2026 | finance.yahoo.comRathbones Group PLC Sells 18,632 Shares of DexCom, Inc. $DXCMMay 22, 2026 | marketbeat.comFideuram Intesa Sanpaolo Private Banking S.P.A. Makes New $1.86 Million Investment in DexCom, Inc. $DXCMMay 22, 2026 | marketbeat.comDexCom Might Finally Be Cheap EnoughMay 21, 2026 | seekingalpha.comLeonteq Securities AG Takes $2.12 Million Position in DexCom, Inc. $DXCMMay 21, 2026 | marketbeat.comHandelsbanken Fonder AB Sells 230,974 Shares of DexCom, Inc. $DXCMMay 21, 2026 | marketbeat.comLive Longer and Better. Does Medicine’s New Obsession Really Work?May 21, 2026 | finance.yahoo.comThe DexCom Stock Turnaround Is Showing Real Signs of LifeMay 20, 2026 | barchart.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesThe Real SpaceX Play: 5 Chip Stocks Powering the IPO Before It LaunchesBy Bridget Bennett | May 4, 2026Apple Talks Just Changed Everything for IntelBy Sam Quirke | May 6, 20263 Energy Stocks to Buy and 2 to Avoid as AI Power Demand ExplodesBy Bridget Bennett | May 4, 2026Sell in May and Go Away—Starting With These 3 StocksBy Bridget Bennett | May 12, 20263 Reasons Analysts Love DexComBy Nathan Reiff | May 5, 2026DXCM Company DescriptionsDexCom NASDAQ:DXCM$71.72 -0.38 (-0.53%) As of 10:10 AM EasternDexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/18 - 05/22 Ross Stores Earnings Beat Sends Stock To New Highs Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus? Workday Validates AI Flywheel: Stock Price Recovery Begins Alphabet Just Unveiled Its Most Ambitious AI Lineup Yet Apparel Earnings Winners and Losers: Ralph Lauren Takes Off SpaceX IPO: Opportunity? Or the Ultimate Hype Trade? The Careful Consumer: What Q1 Earnings Reveal—And Where Cracks May Appear Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
